OMICS International announces the 5th International Conference on Clinical & Experimental Ophthalmology to be held during August 04-06, 2015 at Valencia, Spain, with a slogan “Scientific eye for visual intelligence”.
Enormous expansion is taking place in basic research and clinical trials for the development of cutting-edge technology in Ophthalmology. The growing challenges of ophthalmic diseases, like Corneal disease infective condition of the cornea, Macular Degeneration are major cause of blindness and visual impairment in older adults (>50 years), Nystagmus uncontrollable movements of the eyes, Conjunctivitis, cataract, retinal detachment, refractive surgery, and glaucoma and Retinoblastoma including diabetic retinopathy has reached epidemic dimensions, and a myriad of treatment possibilities are being explored in different directions. The fields of dry eye, cataract surgery, oculoplastics, advances in IOLs, and socioeconomic issues also have contributed to the need to debate many controversial issues, which come up in clinical situations.
Changing trends in diet and lifestyle as well as increased longevity are growing the market for ophthalmological treatments: the global ophthalmic device market is expected to reach $28billion by 2016, exhibiting a 2.5% compound annual growth rate from 2009 to 2016, according to GBI Research. “The worldwide ophthalmic products market exceeds $22 billion and is growing at more than 10% per year. Without the inclusion of consumer eye care products, the ophthalmic products market is roughly a $17 billion. Rising demand for ophthalmic devices and expanding healthcare coverage in emerging economies will increase sales by 2024. The overall medical devices market in Europe is projected to reach EUR ~ million in 2018, augmenting the CAGR to 3.9% during 2013-2018.
The medical device market of Europe is mainly comprised of medical equipments and ophthalmic devices are manufactured in Germany, France, the UK, Italy and Spain. The demand for medical devices has been growing owing to a mounting awareness for early diagnosis and treatment of countless disease states in European countries. Germany is one of the major European markets that contribute immensely to the exports of medical devices. The overall medical devices market in Europe is projected to reach EUR ~ million in 2018, augmenting at a CAGR of 3.9% during 2013-2018.
According to “About Europe” 1.5 million blind children in the world; 72,000 of them live in Europe, the United States, and Japan. The available data indicate that the prevalence of childhood blindness in Europe is between 0.1 and 0.41 per 1000 children. Retinal disorders, optic atrophy, and lesions of the higher visual pathways are the main anatomical causes of visual loss in children. Keeping the above factors in mind, Valencia, Spain has been selected as venue for 5th International Conference on Clinical & Experimental Ophthalmology. The conference brings together a unique international mix of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.